MMP2 and neoplasm: These dual‐responsive liposomes enable improved biodistribution and on‐demand release of immune checkpoint inhibitor (ICI) molecules within tumor regions via specific cleavage of tumor regionally secreted MMP‐2 enzymes following injection.